| Name | Title | Contact Details |
|---|
Technogym is a Seattle, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
APA Service Center is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hospital Patient Services is a Phoenix, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Tammany Parish Hospital delivers today`s life-improving procedures with the latest technology, highest quality and the utmost care to area residents. From wellness and prevention to diagnosis, treatment, rehabilitation and recovery, the St. Tammany Parish Hospital system delivers the very latest technology, the most accomplished specialists and highly personalized, caring staff to ensure patients and their families receive world-class healthcare close to home. St. Tammany has higher quality ratings from The Joint Commission (qualitycheck.org) than other hospitals in our region. STPH consistently earns national and local recognition for quality, innovation and patient satisfaction from Press Ganey, Reuters Thomson, VHA Leadership Awards, Employer of Choice, Best Places to Work and Best of the Northshore rankings. Please tell any member of the staff, a supervisor or the Guest Services Department (898-4669) if there is anything we can do to make a patient`s stay more comfortable. We want the opportunity to address it. St. Tammany Parish Hospital is accredited by The Joint Commission, whose standards deal with quality and safety of care and environment. Patients have the right to contact the Joint Commission`s Office of Quality Monitoring for concerns about your care either by calling (800) 994-6610 or by visiting jointcommission.org/. You may also speak with the Louisiana Department of Health and Hospitals by calling (225) 342-6429 or the U.S. Department of Health and Human Services at (877) 696-6775. St. Tammany Parish Hospital campuses are completely tobacco-free. As the largest healthcare provider in the parish, we eliminated tobacco as part of our mission to serve the community`s healthcare needs. We recognize adults` right to use tobacco but we know its ill effects and institute this policy for the safety and health of our patients, families, employees, volunteers and physicians. Thank you for not smoking. STPH is a self-supporting not-for-profit community hospital; it receives no tax funding.
TherOx, Inc. (TherOx) is a private, venture-financed medical device company based in Irvine, California, dedicated to elevating the standard of care for treatment of heart attack patients. A heart attack is caused when an artery in the heart becomes blocked. Current treatment of heart attack is to reestablish blood flow in the blocked artery as quickly as possible. Typically, this is done with a combination of medication and a percutaneous coronary intervention (PCI) which may include the placement of a (intracoronary) stent. PCI successfully restores blood flow, but damage to the patient’s heart remains. Blood flow in the microvasculature downstream from the blockage is compromised, and critical heart muscle tissue is damaged – or infarcted – due to oxygen deprivation brought on by the heart attack. The intent of SuperSaturated Oxygen (SSO2) Therapy from TherOx is to salvage damaged heart tissue by placing a high concentration of oxygen (~760 – 1,000 mmHg, or 5 – 7 times normal levels) into the patient’s blood plasma and delivering it directly to the area impacted by the heart attack. SSO2 Therapy serves as a complement to PCI and stenting. Immediately following the interventional procedure, proprietary technology from TherOx mixes a pre-specified concentration of “SuperOxygenated” saline solution with the patient’s blood to produce SuperOxygenated blood. The SuperOxygenated blood is then delivered through a catheter to the oxygen deficient tissue. Company research has confirmed in clinical studies that SuperSaturated Oxygen Therapy has the potential to reverse ischemia and may resuscitate tissue that may otherwise die. SSO2 Therapy circulates the patient`s own blood via the existing arterial access site used for the stenting procedure. Thus, no new access site is required. The TherOx DownStream System and DownStream Cartridge bear the CE Mark but are not available for commercial distribution in the EU at this time.